Methods and compositions relating to CD39-like polypeptides...

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S388260, C530S389100, C530S391300, C530S350000, C435S326000, C435S810000

Reexamination Certificate

active

06884872

ABSTRACT:
The present invention provides polynucleotides and proteins encoded by such polynucleotides, along with therapeutic, diagnostic and research utilities for these polynucleotides and proteins. In particular, the polypeptides and polynucleotides of the invention comprise amino acid and nucleic acid sequences of novel CD39-like gene and gene products.

REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4737323 (1988-04-01), Martin et al.
patent: 4837028 (1989-06-01), Allen
patent: 4946778 (1990-08-01), Ladner et al.
patent: 4959314 (1990-09-01), Mark et al.
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5202231 (1993-04-01), Drmanac et al.
patent: 5525464 (1996-06-01), Drmanac et al.
patent: 6476211 (2002-11-01), Ford et al.
patent: 2148851 (1996-10-01), None
patent: WO 9003382 (1990-04-01), None
patent: WO 9014148 (1990-11-01), None
patent: WO 9109955 (1991-07-01), None
patent: WO 9220808 (1992-11-01), None
patent: WO 9412650 (1994-06-01), None
patent: WO 9509248 (1995-04-01), None
patent: WO 9630532 (1996-10-01), None
patent: WO 9632471 (1996-10-01), None
patent: WO 0004041 (2000-01-01), None
Smith et al, Biochim Biophys Acta 1386(1): 65-78, Jul. 1998.*
Harlow et al, in Antibodies a Laboratory Manual, 1998, Cold Spring harbor laboratory publication, Cold Spring Harbor, NY, pp. 92-94, pp. 116-117, and pp. 626-629.*
Campbell et al, in Monoclonal Antibody Technology, 1984, Elsevier Science Publisher, New York, NY, pp. 1-32.*
Hicks-Berger, C.A. et al., “Expression and Characterization of Soluble and Membrane-bound Human Nucleoside Triphosphate Diphosphohydrolase 6 (CD39L2),”J. Biol. Chem.,275(44):34041-34045 (2000).
Chadwick, B.P. et al., “Cloning and Mapping of a Human and Mouse Gene with Homology to Exto-ATPase Genes,”Mammalian Genome,8:668-672(1997).
Chadwick, B.P. et al. “cDNA Cloning and Chromosomal Mapping of a Mouse Gene with Homology to NTPases,”Mammalian Genome,9:162-164 (1998).
Chadwick B.P. et al., “The CD39-like Gene Family: Identification of Three New Human Members (CD36L2, CD39L3, and CD39L4). Their Murine Homologues, and a Member of the Gene Family fromDrosophila melanogaster,” Genomics,50:357-367(1998).
Smith, T.M.. et al., “Cloning, Sequencing, and Expression of a Human Brain Exto-Apyrase Related to Both the Ecto-ATPases and CD39 Ecto-Apyrases,”Biochim. Biophys Acta,1386:65-78 (1998).
Adelman, J. P. et al., “In Vitro Deletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone,”DNA,2:183-193 (1983).
Mulero, J.J. et al., “CD39-L4 Is a Secreted Human Apyrase, Specific for Hydrolysis of Nucleoside Disphosphates,”J. Biol. Chem.,274(29): 20064-20067 (1999).
Altschul, S.F. et al., “Basic Local Alignment Search Tool,”J. Mol. Biol.,215:403-410 (1990).
Altschul, S.F., “A Protein Alignment Scoring System Sensitive at All Evolutionary Distances,”J. Mol. Evol.,36:290-300 (1993).
Anderson, W.F., “Human Gene Therapy,”Nature(Suppl), 392:25-30 (1988).
Asseline U. et al., “Nucleic Acid-Binding Molecules with High Affinity and Base Sequence Specificity: Intercalating Agents Covalently Linked to Oligodeoxynucleotides,”Proc. Natl. Acad. Sci., USA,81:3297-3301 (1984).
Bayer, E. A. et al., “The Avidin-Biotin Complex in Affinity Cytochemistry,”Meth. Enzym.,62:308-315 (1979).
Beal, P.A. et al., “Second Structural Motif for Recognition of DNA by Oligonucleotide-Directed Triple-Helix Formation,”Science,251:1360-1363 (1991).
Bonaldo M. et al., “Normalization and Subtraction: Two Approaches to Facilitate Gene Discovery,”Genome Res.,6:791-806 (1996).
Boorstein et al., “Primer Extension Analysis of RNA,”Methods Enzymol., 180:347-369 (1989).
Breslauer K.J. et al., “Predicting DNA Duplex Stability from the Base Sequence,”Proc. Natl. Acad. Sci., USA,83:3746-3750 (1986).
Broude, N.E. et al., “Enhanced DNA Sequencing by Hybridization,”Proc. Natl. Acad. Sci., USA,91: 3072-3076 (1994).
Brumbaugh J.A. et al, “Continuous, On-line DNA Sequencing Using Oligodeoxynucleotide Primers with Multiple Fluorophores,”Proc. Natl. Acad. Sci., USA,85:5610-5614 (1988).
Burnstock, G., “The Past, Present and Future of Purine Nucleotides as Signalling Molecules,”Neuropharmacology,36:1127-1139 (1997).
Cate R.L. et al. “Genomic Southern Analysis with Alkaline-Phosphatase-Conjugated Oligonucleotide Probes and the Chemiluminescent Substrate AMPPD,”Genet. Anal. Tech. Appl.,8(3):102-106 (1991).
Cole, S.P.C. et al., “The EBV-Hybridoma Technique and It's Application to Human Lung Cancer,”Monoclonal Antibodies and Cancer Therapy,Alan R. Liss, Inc., pp. 77-96 (1985).
Communi, D. et al., “Cloning, Functional Expression and Tissue Distribution of the Human P2Y6Receptor,”Biochem. Biophys. Res. Com.,222:303-308 (1996).
Cooney, M. et al., “Site-Specific Oligonucleotide Binding Represses Transcription of the Human c-myc Gene in Vitro,”Science, 15241:456-459 (1988).
Craig, M.E. et al., “Relaxation Kinetics of Dimer Formation by Self Complementary Oligonucleotides,”J. Mol. Biol.,62:383-401 (1971).
Dahlén et al., “Sensitive Detection of Genes by Sandwich Hybridization and Time-Resolved Fluorometry,”Mol. Cell. Probes(England), 1:159-168 (1987).
Daly, J. et al., Direct Method for Determining Inorganic Phosphate in Serum with the “CentrifiChem”,Clin. Chem.,18:263-265 (1972).
Dolinnaya et al., “Site-directed Modification of DNA Duplexes by Chemical Ligation,”Nucleic Acids Research,(England) 16(9):3721-3738 (1988).
Dolinnaya, N.G. et al., “The use of BrCN for assembling modified DNA duplexes and DNA-RNA hybrids; comparison with water-soluble carbodiimide,”Nucleic Acids Res.,(England),19(11):3067-72 (Jun., 1991).
Drmanac, R. et al., “A calculation of fragment lengths from human DNA with 78 restriction enzymes: an aid for cloning and mapping,”Nucleic Acids Research,14(11): 4691-4692 (1986).
Drmanac, R et al., Sequencing of Megabase Plus DNA by Hybridization: Theory of the Method,Genomics,4:114-128 (1989).
Drmanac R. et al., “Reliable Hybridization of Oligonucleotides as Short as Six Nucleotides,”DNA Cell Biol.,9:527-534 (1990).
Drmanac, R. et al., “An Algorithm for the DNA Sequence Generation from k-Tuple Word Contents of the Minimal Number of Random Fragments,”J. Biomol. Struct. Syn., 8(5):1085-1102 (1991).
Drmanac, R. et al., “Sequencing By Oligonucleotide Hybridization: A Promising Framework in Decoding of the Genome Program?”Proceedings of the First International Conference Electrophoresis Supercomputing Human Genome,Cantor et al., (Eds.), World Scientific Publishing Co., Singapore, pp. 47-59 (1991).
Drmanac, R. et al., “W (A or T) Sequences as Probes and Primers Suitable for Genomic Mapping and Fingerprinting,”Nucleic Acids Research,19(21):5839-5842 (1991).
Drmanac et al., “DNA Sequence Determination by Hybridization: A Strategy for Efficient Large-Scale Sequencing,”Science, 260(5114):1649-1652 (1993).
Drmanac, S. et al., “Processing of cDNA and Genomic Kilobase-Size Clones for Massive Screening, Mapping and Sequencing by Hybridization,”Biotechniques,17:329-329, 332-336 (1994).
Dubyak, G. R. et al., “Signal Transduction via P2-Purinergic Receptors for Extrecellular ATP and Other Nucleotides,”Am. J. Physiol. 34:C577-C606 (1993).
Duncan, C.H. et al., “Affinity Chromatography of a Sequence-Specific DNA Binding Protein using Teflon-linked Oligonucleotides,”Anal. Biochem.,169:104-108 (1988).
Engval, E. et al., Enzyme-Linked Immunosorbent Assay, ELISA III. Quantitation of Specific Antibodies by Enzyme-Labeled Anti-Immunoglobulin in Antigen-Coated Tubes,Immunol.,109:129-135 (1972

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods and compositions relating to CD39-like polypeptides... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions relating to CD39-like polypeptides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions relating to CD39-like polypeptides... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3425222

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.